In animals injected with a bolus of isoproterenol, fi-adrenergic receptors in both mononuclear leukocytes (MNL) and heart were sequestered away from the cell surface, and the time course (0-120 min) and dose-response patterns were similar in the two tissues. In guinea pigs given a constant infusion of isoproterenol, 0.15 mg/(kg * h), down-regulation of total receptor number occurred more quickly and to a greater extent in the MNL than in the heart.
Introduction
Stimulation of,B-adrenergic receptors by agonists activates adenylate cyclase, but with continued stimulation receptormediated responses become blunted or desensitized. This agonist-promoted desensitization has been observed with a variety of cell types. Several different molecular mechanisms of desensitizations have been proposed (1, 2) . One of these is the rapid (less than a few minutes) redistribution or internalization of p-receptors into membrane vesicles where the receptors are uncoupled from the stimulatory guanine nucleotide-binding protein (G,)1 and from the catalytic unit of adenylate cyclase.
Two methods have been used to discriminate between receptors on the cell surface and those in intracellular vesicles. One is to fractionate cell homogenates by differential centrifugation; receptors present in very light membrane fractions are presumed to represent intracellular receptors (1, 3, 4) . The second method is to use intact cells and to compare the binding of a hydrophobic antagonist with that of the hydrophilic fB-adrenergic antagonist CGP-12177, which binds to cell surface receptors but cannot penetrate the cell membrane to detect intracellular receptors (5) (6) (7) . Although redistribution of receptors by agonists occurs in a few minutes, down-regulation (of receptor number) occurs with a time course of hours or days. These two events, j3-adrenergic receptor redistribution and fl-adrenergic receptor down-regulation, may contribute to the pathophysiology of various disease states (8, 9) .
Mononuclear leukocytes (MNL) are easily accessible cells for investigating the regulation of human f3-adrenergic receptors (5, 8, 10) . We have found that ,3 agonists added to human MNL in vitro can promote redistribution, and that this redistribution may contribute to desensitization of receptor function (5, 6) . Despite evidence of receptor redistribution from in vitro studies, negligible redistribution of human MNL fl-receptors occurs during vigorous exercise, a 30-min of infusion of isoproterenol, or a 6-d treatment with the f3-adrenergic agonist terbutaline (11, 12) .
The purpose of this study was to explore further the utility of MNL as a mode for receptors on solid tissues. In particular, we have determined whether changes in the number and location of #-receptors on MNL accurately reflect changes in #l-receptors that occur in the heart.
Methods
Infusion ofisoproterenol and induction ofheartfailure. For short timecourse experiments (< 120 min) male Hartley guinea pigs (400-500 g, 4-6 wk, Simonsen Co.) received either (-)-isoproterenol (0.05-0.2 mg/kg in 10 mM HCl) or 10 mM HCl by subcutaneous injection. For longer time periods the animals were anesthetized with ketamine (1 10 mg/kg i.m.) and Alzet model 2001 or 2002 osmotic minipumps (Alza Corp., Palo Alto, CA) were then implanted subcutaneously. These minipumps were used to deliver isoproterenol or vehicle (HCl 10 mM) at a rate of 0.15 mg/(kg h) for up to 21 d. At the desired time of sacrifice, animals were anesthetized with ketamine (80 mg/kg i.m.) and xylazine (8 mg/kg i.m.), and blood was obtained via direct left ventricular puncture and mixed with EDTA (5 mM final) and placed on ice. Plasma was frozen for subsequent determination of isoproterenol and norepinephrine levels, which were measured radioenzymatically (13) . The heart was removed and perfused with ice-cold 50 mM Tris-HCI (pH 7.4), and the left ventricle was trimmed and frozen at -70'C.
To establish an acute pressure overload on the heart, animals were anesthetized with ketamine/xylazine, intubated, and ventilated with supplemental oxygen on a Harvard respirator (Harvard Apparatus Co., Inc., S. Natick, MA). A left thoracotomy was performed and a metal clip was placed around the ascending aorta causing an 80-90% constriction for 1 h. This usually led to rapid cardiac dilatation, sympathetic stimulation, elevated norepinephrine levels, and hypotension. 6 of 36 animals did not survive for 1 h (range of survival, 5-20 min) and these were excluded from analysis. At the time of sacrifice (1 h) left ventricular pressure was obtained via a 22-gauge needle attached to a pressure transducer, blood was obtained, and the heart was removed as described above. A control group of animals underwent thoracotomy without subsequent aortic constriction.
Lymphocyte preparation and radioligand binding. Techniques for preparation of guinea pig lymphocytes and radioligand binding to f3-receptors involved modifications of previous studies with human cells (5, 6, 14) . At the time of sacrifice of animals, blood was immediately placed into tubes containing EDTA (5 mM final) and was transferred into tubes containing an equal volume ice-cold PBS. All steps thereafter were performed at 40C. The blood was centrifuged at 500 g and the platelet rich plasma was removed. An equal volume of PBS was added, the tube was centrifuged at 500 g again, and the supernatant was discarded. PBS was added to bring the volume to twice that of the starting blood volume. 10 ml of Ficoll-Hypaque was subfused slowly and samples were then centrifuged at 1400 rpm for 15 min. MNL were collected from the interface and washed three times in PBS and then resuspended in Dulbecco's modified Eagle's medium with 20 mM Hepes (DMEH, pH 7.4) and 1 mg/ml bovine serum albumin.
This method involves longer and faster centrifugations than those typically used for preparation of human MNL (5, 14) ; this was necessary to prepare MNL free ofplatelets and red cells. Over 90% ofcells were able to exclude trypan blue. Radioligand binding were conducted in a total volume of 0.5 ml DMEH containing 2-3 X 105 MNL, varying concentrations of -['25IJiodopindolol (IPIN) between 10 pM and 120 pM and either buffer, 1 gM (-)-propranolol (Ayerst Laboratories New York, NY), or 1 MM CGP 12177 (kindly provided by Dr. M. Staehelin, Ciba Geigy, Basel, Switzerland). Incubations were continued at 4VC for 40 h, at which time the cells were filtered over Whatman GF/C filters (Whatman Inc., Clifton, NJ) and washed in 20 ml of PBS at room temperature. This lengthy incubation was necessary to achieve steady state in binding to sequestered receptors at 4VC (5) . The difference between total binding and binding in the presence of propranolol represents the total number of receptors; the difference between total binding and binding in the presence of CGP-12177 represents surface receptors (5, 6) . The number of sequestered or redistributed receptors is defined as the total number ofreceptors minus the number ofsurface receptors. Studies with flI and 2 selective agents indicate that guinea pig MNL possesses a pure population of 02-adrenergic receptors, as do human MNL (5 and data not shown).
cAMP accumulation in MNL. Incubations were begun by adding 0.1 ml of ice-cold cells (2-5 X 105) to 0.9 ml of DMEH at 370C containing, 1 mg/ml BSA, 1 mM isobutylmethylxanthine, and 0.1 mM Ro-1724 (kindly provided by Dr. H. Sheppard, Roche Laboratories, Nutley, NJ) to inhibit phosphodiesterase activity, 10 Mg/ml superoxide dismutase and 10 ug/ml catalase (to prevent oxidation of isoproterenol [15] ) in the absence or presence of 10 uM isoproterenol.
The incubation was stopped after 2 min by centrifugation at 10,000 g.
The supernatant was aspirated and the pellet was resuspended in 100 M1 50 mM sodium acetate (pH 4.0) and 0.2 mM isobutylmelthyxanthine. The tubes were placed in a boiling water bath for 5 min, and then were frozen. Aliquots were assayed for cAMP using a competitive binding protein method as previously described (5, 1 1). Preparation ofsarcolemmal and light vesicle membranes and assay off-adrenergic receptors in cardiac membranes. We isolated two fractions from excised left ventricles; a purified sarcolemmal fraction in which f3-adrenergic receptors are responsive to agonist, and a lighter membrane fraction of receptors that are unresponsive to agonist. Details of this method have been described previously (3, 16) . Briefly, after extraction ofcontractile proteins with 750 mM NaCI, the samples were rigorously homogenized. A "crude" fraction was isolated by removal of the supernatant of a 500-g centrifugation. The light vesicle fraction was obtained by centrifuging the supernatant of a 45,000-g centrifugation at 137,000 g for 90 min. We have previously shown that receptors in this light vesicle fraction are functionally uncoupled from GO (the stimulatory guanine nucleotide binding protein) and that this fraction has little adenylate cyclase, 5'-nucleotidase, or Na'-K' ATPase activity and is not enriched in markers for lysosomes or mitochondria (17) . Sarcolemmal membranes were obtained by serial washings of the pellet of the 45,000-g centrifugation and then taking the supernatant of a 17,000-g centrifugation and centrifuging at 137,000 g. The resulting rim above the pellet was considered the sarcolemma fraction and is enriched in adenylate cyclase and Na'-K+-ATPase activity;
binding ofagonist to fl-adrenergic receptors in this fraction is regulated by guanine nucleotides (17) (18) (19) . Protein was determined by the method of Lowry using bovine serum albumin as the protein standard (20) .
Binding of ['25I]iodocyanopindolol (ICYP) to f3-adrenergic receptors was measured by incubating membranes in triplicate with varying concentrations of radioligand (50-600 pM) at 250C for 1 h. Binding was terminated by diluting samples to 10 ml with ice-cold buffer, filtering over Whatman GF/B filters that had been presoaked in 2% polyethyleneimine and washing the filters with 10 ml of ice-cold buffer. We used filters soaked in polyethyleneimene to minimize loss of receptors that might be present in small membrane fragments and that might therefore not be trapped in untreated glass fiber filters (21) . Radioactivity retained on filters was determined using a gamma counter at 86% efficiency. Nonspecific binding for both sarcolemmal and light vesicle fractions was determined by ['251]ICYP binding in the presence of I MM(-)-propranolol and was routinely 10-20% of total binding for both membrane fractions.
Adenylate cyclase assay. Adenylate cyclase was assayed by the method of Salomon et al. (22) in a buffer containing 50 mM Tris-HC1, 10 mM Mg C12, 0.3 mM cAMP, 1 mM ATP, 100 MM GTP, 20 mM creatine phosphate, 50 U/ml creatine phosphokinase, 800,000 cpm [32P]ATP, and in some tubes 100 MM isoproterenol, 10 MM forskolin, or 10 MM guanylylimidodiphosphate [Gpp(NH)p]. Incubations lasted 20 min at 30°C and cAMP was isolated by sequential chromatography, using Dowex (Dow Coming Corp., Midland, MI) and alumina. Data analysis. Radioligand binding data were analyzed using a computer program that performs iterative nonlinear regression to fit the specific binding to an equation describe binding of ligands to a single class of homogeneous binding sites. The experiments were all performed with triplicate data points and were conducted at least twice with similar results. Unless stated otherwise, the data are presented as mean±SE of the mean. To determine statistical significance of we calculated unpaired two-tailed t tests.
Results
In vitro redistribution of f-adrenergic receptors on MNL by isoproterenol. We have previously demonstrated that incubating human blood with 10 ,M isoproterenol for 10 min redistributed up to 50% of the ,B-adrenergic receptors on MNL without changing the total receptor number (5, 1 1). Guinea pig MNL contained 912±83 j3-adrenergic receptor sites per cell with a Kd for [251I]IPIN of 0.03±0.004 nM (n = 15). Of these 90.2%±0.7% of the receptors were on the cell surface, as defined by the ability of CGP-12177 to inhibit ['251]IPIN binding. Thus, only 10% of 3-receptors were sequestered on MNL under basal conditions. The dose-response pattern for redistribution of fl-receptors produced by incubation of guinea pig blood with isoproterenol in vitro for 10 min is shown in Fig. 1 . The EC50 concentration of isoproterenol was 20 nM. About 50% of the ['251I]IPIN sites were maximally redistributed by isoproterenol (1 MM) in this short-term incubation. These results with guinea pig cells are similar to those previously observed for human cells (5) .
In Vivo Regulation of/-Adrenergic Receptors 2039 Isoproterenol-induced redistribution off-adrenergic receptors on MNL and heart in vivo. Fig. 2 , A and B, shows results of experiments that examine redistribution of 3-receptors on circulating MNL and in heart membranes after subcutaneous injection ofguinea pigs with 0. 15 mg/kg ofisoproterenol. Each time point in Fig. 2 A represents the pooled blood of two to three animals. Loss of receptors from the cell surface occurred within the first 15 min. Between 15 and 90 min the percentage of sequestered receptors remained relatively constant at about 25% of the total receptors. The total number of receptors did not change in the first 90 min but receptor number began to "down-regulate" thereafter. As shown in Fig. 2 within 15 min after isoproterenol administration and this agonist-induced decrease was maximal by 30 min. This decrease in sarcolemmal receptors appeared to represent receptor internalization (i.e., sequestration), as the number of receptors that were detectable in the light vesicle fraction increased over a similar time course. Thus, the kinetics of sequestration of f3-adrenergic receptors in response to a single injection of isoproterenol is similar in MNL and heart. Fig. 3 shows the pooled results of six experiments with two or three animals per experiment, each killed 1 h after isoproterenol injection (0.15 mg/kg). The number of f3-adrenergic receptors on the surface of MNL decreased from 829±73 sites per cell in control to 654±80 sites per cell (a 21% decrease in the number of surface sites). In the heart, the number of sarcolemmal P-receptors decreased from 106±8 to 71±6 fmol/ mg, representing a decrease of 33%. Thus the extent of sequestration (defined as percent of control number of surface sites) after an injection of guinea pigs with 0.15 mg/kg isoproterenol is roughly similar in heart and MNL.
As shown in Fig. 4 , 30 min after injection of isoproterenol, isoproterenol-stimulated cAMP accumulation in MNL and adenylate cyclase activity in sarcolemma were substantially blunted (desensitized). In contrast, the responsiveness of sar- MNL during a 3-wk period that animals were infused with isoproterenol (0.15 mg/kg per h). Substantial down-regulation was observed within the first 24 h. This decrease in receptor number reached a plateau at 20% of control levels between 2 and 21 d. The affinity ofthe receptor for the ligand (Kd) did not significantly change after infusion of isoproterenol.
The sarcolemmal and light vesicle fractions that we isolate from guinea pig heart account for only about 30% of the total pool of cardiac 13-adrenergic receptors (17) . Thus, we also quantitated ,3-receptors in crude cardiac membranes, which would contain a more representative complement of cardiac :-receptors. Fig. 6 B demonstrates the kinetics of agonist-induced down-regulation of 1-receptors on crude cardiac membranes, as well as sarcolemmal and light vesicle membranes, for a 3-wk period during which isoproterenol was infused via osmotic minipumps. Down-regulation of 1-receptors in the crude cardiac membranes occurred after 2 2 days. The number of light vesicle 13-adrenergic receptors decreased in parallel with the loss in fl-adrenergic receptors in the crude cardiac membranes. The loss in surface sarcolemmal 1-receptor occurred more rapidly but ultimately to a similar extent as the loss in light vesicle and crude cardiac membrane receptors. Thus, whereas isoproterenol administration produced a rapid sequestration of1-adrenergic receptors that occurred with sim- .20 tive of two to three ex-L (mg/kg) periments. ilar rates in heart and MNL, isoproterenol-stimulated downregulation of receptors occurred somewhat more slowly and to a lesser extent in the heart than in MNL.
Comparison of1-adrenergic receptor sequestration in heart and MNL after an acute pressure overload on the heart. The data presented so far indicate that redistribution of1-receptors on MNL and heart occurs similarly in response to high concentrations of circulating agonist. Concentrations of catecholamines are much higher at sympathetic nerve-effector cell synapses, and we wondered whether changes in synaptic levels of catecholamines would lead to receptor redistribution. To test this idea we created an acute increase in cardiac afterload by constricting the aorta. This increases the sympathetic drive and leads to the development of acute heart failure, with plasma norepinephrine levels nearly four times those of controls: 16,930±406 pg/ml (100 nM) vs. 4,772±457 (28 nM) (P < 0.01). The plasma norepinephrine level was high in control animals, presumably due to thoracotomy. The left ventricular end diastolic pressure was 18±6 mM Hg in pressure overloaded animals vs. 8±3 in sham-operated controls (P < 0.05).
In animals with aortic constriction the number of surface f1receptors decreased an average of 9% on MNL and 61% in heart. In 7 of 10 animals, the loss of 1-adrenergic receptors from the surface membrane was greater in heart than in MNL and overall the difference between heart and MNL was signifi- Corresponding to the decrease in 13-adrenergic receptor with aortic construction, isoproterenol-stimulated adenylate cyclase activity was decreased by 17% in a crude membrane preparation (n = 6 for each group, P < 0.05). Pooled sarcolemma from three animals each (n = 2) revealed a decrease in isoproterenol-stimulated adenylate cyclase of 30%.
Discussion
Because MNL are easily accessible, assays of 13-adrenergic receptors on human MNL have been used as a possible marker of receptors on less accessible tissues. Several studies demonstrate that changes in 1-receptor number or response on MNL mirror those on other tissues (e.g., 10, 23-26). For example, recent data in 21 human subjects show a good correlation between total 1-receptor number in membranes prepared from MNL and right atrial appendage (10) . Comparisons between 1-receptor expression on MNL and other tissues may be complicated because 13-adrenergic receptors on MNL are exclusively ofthe 132-subtype while receptors on other tissues such as heart, adipocytes, and kidney are predominantly of the Aksubtype. The current study has used an animal model to examine possible differences in receptor compartmentation between MNL and the heart. Relatively little previous information has been available regarding 13-adrenergic receptor compartmentation in tissues in vivo. We had previously developed a method of studying redistribution of 1-adrenergic receptors on intact human mononuclear leukocytes (MNL), and had found that although most of the receptors were redistributed after in vitro incubation of MNL with agonist, only minimal redistribution was observed in vivo after 30 min of exercise, 2 h of isoproterenol infusion, or 6 d of terbutaline (6, 12) . Plasma catecholamine concentrations in these protocols did not reach the very high levels (2 100 nM) seen in some clinical settings (i.e., pheochromocytoma, shock, or perhaps myocardial infarction), but these data suggested that redistribution of 13-adrenergic receptors on MNL does not generally occur under physiological circumstances. These observations led us to question whether receptor redistribution on MNL accurately mirrors that of other cell types.
The method used in this study for assessing redistribution of 13-adrenergic receptors on guinea pig MNL was similar to that used in previous studies with human MNL, and results after in vitro incubation with agonist were also similar. It is important to note that these methods employ intact MNL, while our methods for assessing redistribution of 13-adrenergic receptors on guinea-pig heart involve subcellular fractionation of membrane preparations. With intact MNL, our methods measure two receptor compartments: receptors accessible to CGP-12177 (surface) and those that are not (sequestered). In contrast, we measure 13-adrenergic receptors in three cardiac fractions: crude, sarcolemmal, and light vesicle. These methodologic differences do not permit an ideal comparison between MNL and heart. Another difference also hinders direct comparison between the two tissues. In studies with MNL, we are able to quantitate receptors as sites per cell. With receptor redistribution, therefore, the loss of surface receptors is reflected by an equal increase in the number of sequestered receptors. By contrast, in studies with the heart, we quantitate receptor number in each fraction as femtomoles per milligram of protein, even though the protein composition of the different fractions is likely to be quite different. Thus, when receptors are redistributed, the decrease in receptor density (femtomoles per milligram) in the sarcolemmal vesicles will not necessarily equal the increase in receptor density (femtomoles per milligram) in the light vesicles. To circumvent these two problems, we have focused our data analysis on the relative change in the number ofreceptors in the surface fractions in MNL and heart, as these are functionally active receptors.
In guinea pigs injected with isoproterenol, redistribution of 13-adrenergic receptors occurred both in heart and MNL. Both the time course and the dose-response relationship were similar in the two tissues. The greater redistribution observed in guinea pig MNL relative to earlier in vivo studies with humans, probably reflects the greater dose of agonist administered. Likewise, agonist-induced receptor down-regulation was similar in MNL and heart, although it occurred faster and to a somewhat greater extent in MNL. In the heart this down-regulation was observed for light vesicles as well as sarcolemma P-receptors. The differences probably reflect more than just a difference between 1B,and p32-receptors, inasmuch as other work from our laboratory has demonstrated that renal 1Bkand 132-adrenergic receptors down-regulate with similar kinetics in vivo (27, 28) . Except for the difference in the rate ofdown-regulation, the current data demonstrate that 13-adrenergic receptors on MNL respond to circulating isoproterenol in a manner generally similar to that of receptors on the myocardium. Thus changes observed in the number, location, and function of 13-adrenergic receptors produced by circulating nonselective agonists in human MNL are likely to reflect changes that also occur for f1-adrenergic receptors in the heart (and perhaps other organs).
In contrast, we found aortic constriction selectively redistributed 3-receptors in the heart but not MNL. Two factors are likely to account for this difference. First, increased sympathetic nervous system activity in the heart results in a concentration of norepinephrine at sympathetic nerve-cardiac cell synapses that can exceed plasma concentration by a factor of 1,000 (29) . Receptors in MNL, in contrast, are exposed only to circulating catecholamines. Second, norepinephrine is selective for #3-(heart) compared to 132-receptors (MNL). The relative contribution of these two factors is not clear, although we suspect that the synaptic location of the norepinephrine rather than its ,13 selectivity is most important in this setting. The circulating norepinephrine concentration was in fact higher in the animals given an isoproterenol infusion (probably due to facilitory presynaptic 12 receptors [30] ) than in the animals with aortic constriction (Table I ), yet far more sequestration of cardiac 13-receptors occurred with the aortic constriction. The discrepancy between the 61% decrease in sarcolemmal 013-receptors and the lesser decrease of isoproterenol-stimulated adenylate cyclase activity after aortic constriction might possibly be explained by enhanced coupling between a reduced number of receptors and the catalytic unit of adenylate cyclase. Since plasma norepinephrine levels were measured at only a single time point, we are unable to define possible differences in the kinetics of norepinephrine increase following aortic constriction and isoproterenol injection. The values represent mean±standard error. n ranges from 6 to 15 because measurements were not performed in all animals. * P < 0.05 vs. control by paired t test. t P < 0.01 vs. control by paired t test. § P < 0.001 vs. control by paired t test. P < 0.001 vs. MNL aortic constriction.
In conclusion, we have compared f3-adrenergic receptor compartmentation in vivo in two tissues to determine whether measurements of MNL (3-receptors are likely to be an accurate model for A-receptors in the heart. The data for animals subjected to aortic constriction demonstrate that MNL (3-receptors do not reflect changes promoted by (,-selective agonists and/or changes that occur at synapses where the catecholamine concentration greatly exceeds that to which MNL are exposed. However, data for animals administered isoproterenol clearly show that MNL and cardiac (-receptors respond very similarly to a circulating agonist that does not discriminate between (3- and (32-receptors. Under these circumstances MNL provide a useful model for (-adrenergic receptors on the heart and perhaps in other solid tissues as well.
